In contrast, EGF exhibited significant differential expression in a more limited subset of cancers, specifically esophageal carcinoma, glioblastoma multiforme, liver hepatocellular carcinoma, lung adenocarcinoma (LUAD), lung squamous cell carcinoma, and pancreatic adenocarcinoma (Figure 1b). Here, EGF is linked to lung adenocarcinoma.